Thursday, August 05, 2010

New clinican trial for T-PLL

I just received the following email. Let us hope this trial also produces significant advances in treating T-PLL!

Good afternoon,

I am contacting you since we recently opened a new trial for T-cell PLL at Stanford. I was made aware of your website from a patient who thought sharing that we have this trial open might be helpful. It is for patients with relapsed or refractory disease and treatment will be with velcade. All of the details are on

Holbrook Kohrt, MD

Here is the web page for recruiting:

Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia

No comments: